SCHEMBL13657451

SCHEMBL13657451

Bn1c(=S)sc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
F12 P00748 1/20 0.39
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
HSD17B10 Q99714 2/20 0.38
HPGD P15428 2/20 0.38
CYP1A2 P05177 1/20 0.38
CHEK1 O14757 1/20 0.36
PDGFRA P16234 1/20 0.36
CDK5 Q00535 1/20 0.36
DYRK1A Q13627 1/20 0.36
LRRK2 Q5S007 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
PARP2 Q9UGN5 1/20 0.36
DRD2 P14416 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KDM4E B2RXH2 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL230331 0.74 F12 (0.59) ALDH1A1F12CYP1A2KDM4EGAA
SCHEMBL3393854 0.69 ALDH1A1 (0.48) ALDH1A1HSD17B10HPGDCYP1A2DRD2
SCHEMBL11783847 0.69 ALDH1A1 (0.44) ALDH1A1F12HSD17B10HPGDCYP1A2
SCHEMBL513869 0.69 ALDH1A1 (0.48) ALDH1A1F12HSD17B10HPGDCYP1A2
SCHEMBL20422073 0.69 ALDH1A1 (0.38) ALDH1A1F12HSD17B10HPGDCYP1A2
SCHEMBL19546228 0.69 ALDH1A1 (0.38) ALDH1A1F12HSD17B10HPGDCYP1A2
SCHEMBL9779136 0.69 F12 (0.36) ALDH1A1F12HSD17B10HPGDCYP1A2
SCHEMBL8079249 0.69 ALDH1A1 (0.51) ALDH1A1HSD17B10HPGDCYP1A2DRD2
SCHEMBL19514739 0.68 ALDH1A1 (0.47) ALDH1A1F12HSD17B10HPGDCYP1A2
SCHEMBL6547890 0.67 ALDH1A1 (0.49) ALDH1A1HSD17B10HPGDCYP1A2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090252674-A1 Tripodal Ligands with the Coordinating Motifs K2 -BH2 or K3 -BH3 Relevant for Biomedical Applications of Organometallic Complexes MALLINCKRODT INC. (US) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090252674-A1 Tripodal Ligands with the Coordinating Motifs K2 -BH2 or K3 -BH3 Relevant for Biomedical Applications of Organometallic Complexes BID, BAK1, BCL2L1 ALDH1A1 4414/4885F12 2074/4885CA12 2087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.